ATE200734T1 - Zusammensetzung und verfahren zur verminderung des hypotensionsrisikos - Google Patents

Zusammensetzung und verfahren zur verminderung des hypotensionsrisikos

Info

Publication number
ATE200734T1
ATE200734T1 AT93117796T AT93117796T ATE200734T1 AT E200734 T1 ATE200734 T1 AT E200734T1 AT 93117796 T AT93117796 T AT 93117796T AT 93117796 T AT93117796 T AT 93117796T AT E200734 T1 ATE200734 T1 AT E200734T1
Authority
AT
Austria
Prior art keywords
composition
risk
hypotension
patient
reducing
Prior art date
Application number
AT93117796T
Other languages
English (en)
Inventor
David A Mark
Gary Pace
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Application granted granted Critical
Publication of ATE200734T1 publication Critical patent/ATE200734T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
AT93117796T 1992-11-05 1993-11-03 Zusammensetzung und verfahren zur verminderung des hypotensionsrisikos ATE200734T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/971,949 US5356873A (en) 1992-11-05 1992-11-05 Method for providing nutritional requirements to patients having a chronic inflammation reaction

Publications (1)

Publication Number Publication Date
ATE200734T1 true ATE200734T1 (de) 2001-05-15

Family

ID=25518983

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93117796T ATE200734T1 (de) 1992-11-05 1993-11-03 Zusammensetzung und verfahren zur verminderung des hypotensionsrisikos

Country Status (11)

Country Link
US (1) US5356873A (de)
EP (1) EP0612522B1 (de)
JP (1) JPH0797332A (de)
AT (1) ATE200734T1 (de)
AU (1) AU5040593A (de)
CA (1) CA2109392A1 (de)
DE (1) DE69330177T2 (de)
DK (1) DK0612522T3 (de)
ES (1) ES2157208T3 (de)
GR (1) GR3036272T3 (de)
PT (1) PT612522E (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5585402A (en) * 1992-12-23 1996-12-17 Glaxo Wellcome Inc. Nitric oxide synthase inhibitors
US5378722A (en) * 1993-12-03 1995-01-03 Clintec Nutrition Co. Nutritional compositions for management of nitrogen metabolism
US5576287A (en) * 1994-04-29 1996-11-19 Wake Forest University Method for treating acute renal disease and failure
ATE312622T1 (de) * 1999-04-29 2005-12-15 Novo Nordisk As Verwendung von anti-hbp antikörper zur inhibierung der freisetzung von bradykinin
US6833350B2 (en) 2000-02-04 2004-12-21 Nestec S.A. Method for maintaining or improving the synthesis of mucins
NZ552706A (en) * 2004-07-19 2011-01-28 Nutricia Nv Use of aspartate for regulating glucose levels in blood
WO2007114903A2 (en) * 2006-04-04 2007-10-11 Nestec S.A. Treatments using citrulline
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
SG11202001142VA (en) 2017-08-14 2020-03-30 Axcella Health Inc Amino acid compositions for the treatment of liver disease
US10596136B2 (en) 2018-06-20 2020-03-24 Axcella Health Inc. Compositions and methods for the treatment of fat infiltration in muscle

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4752618A (en) * 1984-07-12 1988-06-21 New England Deaconess Hospital Method of minimizing efects of infection through diet
US4647453A (en) * 1984-10-18 1987-03-03 Peritain, Ltd. Treatment for tissue degenerative inflammatory disease
US4780475A (en) * 1986-02-03 1988-10-25 Cerra Frank B Preparation for the prevention of catabolism
US5055446A (en) * 1988-10-21 1991-10-08 University Of Cincinnati Method to improve survival of patients during sepsis by diet composition
US5158883A (en) * 1989-09-13 1992-10-27 Cornell Research Foundation, Inc. Method of using aminoarginine to block nitric oxide formation in vitro
US5028627A (en) * 1989-09-13 1991-07-02 Cornell Research Foundation, Inc. Method of using arginine derivatives to inhibit systemic hypotension associated with nitric oxide production or endothelial derived relaxing factor
EP0441119A3 (en) * 1990-01-09 1992-10-14 Richard D. Levere The use of l-arginine in the treatment of hypertension and other vascular disorders
CA2036770C (en) * 1990-02-26 2003-09-09 Jeffrey P. Whitten Inhibitors of nitric oxide biosynthesis
ATE174794T1 (de) * 1991-09-27 1999-01-15 Univ Texas Parenteral anzuwendende aminosäuren enthaltende zubereitungen zur bekämpfung von hypotension und verwandten pathologien

Also Published As

Publication number Publication date
DE69330177D1 (de) 2001-05-31
EP0612522A1 (de) 1994-08-31
US5356873A (en) 1994-10-18
CA2109392A1 (en) 1994-05-06
GR3036272T3 (en) 2001-10-31
EP0612522B1 (de) 2001-04-25
JPH0797332A (ja) 1995-04-11
DE69330177T2 (de) 2001-09-06
DK0612522T3 (da) 2001-08-13
PT612522E (pt) 2001-08-30
AU5040593A (en) 1994-05-19
ES2157208T3 (es) 2001-08-16

Similar Documents

Publication Publication Date Title
EP0222483A3 (en) Use of gamma-linolenic acid and related compounds in the treatment of endometriosis
ATE215320T1 (de) Nahrungszusammensetzungen in verschiedenen formen
EP1201241B8 (de) Zusammensetzungen enthaltend Capsaicin oder Capsaicin Analoge und ein Anästhetikum
ATE209864T1 (de) Zusammensetzung zur behandlung von patienten mit lebererkrankungen
DE69230046D1 (de) 2-Bromomelatonin zur Behandlung von Schlafstörungen
TW336171B (en) Pharmaceutical composition for use in the treatment of vulvar dystrophy and/or vaginal dryness
DE69330177D1 (de) Zusammensetzung und Verfahren zur Verminderung des Hypotensionsrisikos
DE3680271D1 (de) Thrombolytische zusammensetzung und verfahren zu deren herstellung.
EP0502925A4 (en) Method and composition for treating inflammatory bowel disorders
EP0934748A3 (de) Von Willenbrand Faktor (vWF) enthaltende Zubereitung, verfahren zür Herstellung von vWF enthaltenden Zubereitungen und deren Verwendung
SG50339A1 (en) Fatty acid derivatives
EP0502313A3 (en) Method for insuring adequate intracellular glutathione in tissue
DE69227042D1 (de) Verfahren und zusammensetzungen zur verminderung von blutverlust
EP0158880A3 (en) Liposomes with inhalable allergens for treatment of allergies, method for their preparation and pharmaceutical compositions containing them
DE69433923D1 (de) Salbe enthaltend mometason-furoat und salicylsäure zur topischen behandlung von psoriasis
DE69002743D1 (de) Verfahren zur verbesserung der ventilation waehrend des schlafes und behandlung von ventilationsabnormalitaeten, die mit dem schlaf verbunden sind.
TW232014B (de)
HU9701606D0 (en) Use of sulbutiamine to obtain pharmaceutical compositions useful in the treatment of certain psychomotor and psychointellectual disorders
ZA928105B (en) Treatment of anxiety in benzodiazpine-withdrawn patients
ATE302611T1 (de) Humanes wachstumshormon als hilfe gegen unterkühlung
UA25316A (uk) Лікарськиа композиція "ріhосепт" та спосіб лікуваhhя і профілактики іhфекційhо-запальhих захворюваhь слизової оболоhки hоса і гhосоглотки за допомогою цієї композиції
UA15180A (uk) Спосіб коhсервативhого лікуваhhя геhералізоваhого пародоhтиту

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee